In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin

Yeh, 2012, Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis, Ann. Intern. Med., 157, 336, 10.7326/0003-4819-157-5-201209040-00508 Soares, 2012, Novel non-invasive methods of insulin delivery, Expert Opin. Drug Deliv., 9, 1539, 10.1517/17425247.2012.737779 Arbit, 2009, Oral insulin: the rationale for this approach and current developments, J. Diabetes Sci. Technol., 3, 562, 10.1177/193229680900300322 Aoki, 2005, Region-dependent role of the mucous/glycocalyx layers in insulin permeation across rat small intestinal membrane, Pharm. Res., 22, 1854, 10.1007/s11095-005-6137-z Cone, 2009, Barrier properties of mucus, Adv. Drug Deliv. Rev., 61, 75, 10.1016/j.addr.2008.09.008 Blanchette, 2004, Principles of transmucosal delivery of therapeutic agents, Biomed. Pharmacother., 58, 142, 10.1016/j.biopha.2004.01.006 Aijaz, 2006, Tight junctions: molecular architecture and function, Int. Rev. Cytol., 248, 261, 10.1016/S0074-7696(06)48005-0 Sonia, 2012, An overview of natural polymers for oral insulin delivery, Drug Discov. Today, 17, 784, 10.1016/j.drudis.2012.03.019 Chen, 2011, A review of the prospects for polymeric nanoparticle platforms in oral insulin delivery, Biomaterials, 32, 9826, 10.1016/j.biomaterials.2011.08.087 Rekha, 2013, Oral delivery of therapeutic protein/peptide for diabetes - future perspectives, Int. J. Pharm., 440, 48, 10.1016/j.ijpharm.2012.03.056 Liu, 2003, Potential utility of various protease inhibitors for improving the intestinal absorption of insulin in rats, J. Pharm. Pharmacol., 55, 1523, 10.1211/0022357022052 Morishita, 2006, Is the oral route possible for peptide and protein drug delivery?, Drug Discov. Today, 11, 905, 10.1016/j.drudis.2006.08.005 Kamei, 2008, Usefulness of cell-penetrating peptides to improve intestinal insulin absorption, J. Control. Release, 132, 21, 10.1016/j.jconrel.2008.08.001 Khafagy, 2009, Effect of cell-penetrating peptides on the nasal absorption of insulin, J. Control. Release, 133, 103, 10.1016/j.jconrel.2008.09.076 Khafagy, 2012, Oral biodrug delivery using cell-penetrating peptide, Adv. Drug Deliv. Rev., 64, 531, 10.1016/j.addr.2011.12.014 Milletti, 2012, Cell-penetrating peptides: classes, origin, and current landscape, Drug Discov. Today, 17, 850, 10.1016/j.drudis.2012.03.002 Lindgren, 2011, Classes and prediction of cell-penetrating peptides, Methods Mol. Biol., 683, 3, 10.1007/978-1-60761-919-2_1 Kamei, 2013, Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps, J. Pharm. Sci., 102, 469, 10.1002/jps.23364 Kamei, 2009, Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides, J. Control. Release, 136, 179, 10.1016/j.jconrel.2009.02.015 Morishita, 2007, A novel approach using functional peptides for efficient intestinal absorption of insulin, J. Control. Release, 118, 177, 10.1016/j.jconrel.2006.12.022 Khafagy, 2013, One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats, Eur. J. Pharm. Biopharm., 85, 736, 10.1016/j.ejpb.2013.09.014 Asada, 1994, Stability of acyl derivatives of insulin in the small intestine: relative importance of insulin association characteristics in aqueous solution, Pharm. Res., 11, 1115, 10.1023/A:1018928613837 Koren, 2012, Cell-penetrating peptides: breaking through to the other side, Trends Mol. Med., 18, 385, 10.1016/j.molmed.2012.04.012 Foged, 2008, Cell-penetrating peptides for drug delivery across membrane barriers, Expert Opin. Drug Deliv., 5, 105, 10.1517/17425247.5.1.105 Khafagy, 2009, Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins, Int. J. Pharm., 381, 49, 10.1016/j.ijpharm.2009.07.022 Renukuntla, 2013, Approaches for enhancing oral bioavailability of peptides and proteins, Int. J. Pharm., 447, 75, 10.1016/j.ijpharm.2013.02.030 Cárdenas-Bailón, 2013, Microencapsulation techniques to develop formulations of insulin for oral delivery: a review, J. Microencapsul., 30, 409, 10.3109/02652048.2012.742159 Cui, 2009, Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles, Biomacromolecules, 10, 1253, 10.1021/bm900035u Sonaje, 2010, Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery, Biomaterials, 31, 3384, 10.1016/j.biomaterials.2010.01.042 Su, 2012, Protease inhibition and absorption enhancement by functional nanoparticles for effective oral insulin delivery, Biomaterials, 33, 2801, 10.1016/j.biomaterials.2011.12.038 Chuang, 2013, Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an egta-conjugated carrier for oral insulin delivery, J. Control. Release, 169, 296, 10.1016/j.jconrel.2012.11.011 Jain, 2012, Folate-decorated plga nanoparticles as a rationally designed vehicle for the oral delivery of insulin, Nanomedicine (London), 7, 1311, 10.2217/nnm.12.31 Zhang, 2012, Thiolated eudragit nanoparticles for oral insulin delivery: preparation, characterization and in vivo evaluation, Int. J. Pharm., 436, 341, 10.1016/j.ijpharm.2012.06.054 Pappenheimer, 1994, Intestinal absorption and excretion of octapeptides composed of d amino acids, Proc. Natl. Acad. Sci. U. S. A., 91, 1942, 10.1073/pnas.91.5.1942 Kamei, 2013, Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport, J. Pharm. Sci., 102, 3998, 10.1002/jps.23708 Walrant, 2012, Molecular partners for interaction and cell internalization of cell-penetrating peptides: how identical are they?, Nanomedicine (London), 7, 133, 10.2217/nnm.11.165